Dose-dependence of protection from systemic reactions to venom immunotherapy by omalizumab

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

ISSN: 1476-7961

Extent: Online-Ressource

Language: Englisch

Notes: online resource.

Bibliographic citation: Dose-dependence of protection from systemic reactions to venom immunotherapy by omalizumab ; volume:14 ; number:1 ; day:24 ; month:10 ; year:2016 ; pages:1-4 ; date:12.2016
Clinical and molecular allergy ; 14, Heft 1 (24.10.2016), 1-4, 12.2016

Creator: Boni, Elisa

Contributor: Incorvaia, Cristoforo
Mauro, Marina
SpringerLink (Online service)

DOI: 10.1186/s12948-016-0051-2

URN: urn:nbn:de:1111-2016112110714

Rights: Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 14.08.2025, 11:02 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Boni, Elisa
Incorvaia, Cristoforo
Mauro, Marina
SpringerLink (Online service)

Other Objects (12)

Determinants of venom-specific IgE antibody concentration during long-term wasp venom immunotherapy

Determinants of venom-specific IgE antibody concentration during long-term wasp venom immunotherapy

PD41 - Risk factors for side effects during venom immunotherapy in children with hymenoptera venom allergy

PD41 - Risk factors for side effects during venom immunotherapy in children with hymenoptera venom allergy

Omalizumab bei Kinderurtikaria

Hochschulschrift

Omalizumab bei Kinderurtikaria

Observational long-term follow-up study of rapid food oral immunotherapy with omalizumab

Observational long-term follow-up study of rapid food oral immunotherapy with omalizumab

Safety and tolerability of venom immunotherapy: evaluation of 581 rush- and ultra-rush induction protocols (safety of rush and ultra-rush venom immunotherapy)

Safety and tolerability of venom immunotherapy: evaluation of 581 rush- and ultra-rush induction protocols (safety of rush and ultra-rush venom immunotherapy)

Single venom-based immunotherapy effectively protects patients with double positive tests to honey bee and Vespula venom

Single venom-based immunotherapy effectively protects patients with double positive tests to honey bee and Vespula venom

Graffiti | Streetart

venom

Graffiti | Streetart

..venom

Graffiti | Streetart

VENOM

Graffiti | Streetart

VENOM

Graffiti | Streetart

"VENOM"-

Graffiti | Streetart

venom!

Determinants of venom-specific IgE antibody concentration during long-term wasp venom immunotherapy

Determinants of venom-specific IgE antibody concentration during long-term wasp venom immunotherapy

PD41 - Risk factors for side effects during venom immunotherapy in children with hymenoptera venom allergy

PD41 - Risk factors for side effects during venom immunotherapy in children with hymenoptera venom allergy

Omalizumab bei Kinderurtikaria

Hochschulschrift

Omalizumab bei Kinderurtikaria

Observational long-term follow-up study of rapid food oral immunotherapy with omalizumab

Observational long-term follow-up study of rapid food oral immunotherapy with omalizumab

Safety and tolerability of venom immunotherapy: evaluation of 581 rush- and ultra-rush induction protocols (safety of rush and ultra-rush venom immunotherapy)

Safety and tolerability of venom immunotherapy: evaluation of 581 rush- and ultra-rush induction protocols (safety of rush and ultra-rush venom immunotherapy)

Single venom-based immunotherapy effectively protects patients with double positive tests to honey bee and Vespula venom

Single venom-based immunotherapy effectively protects patients with double positive tests to honey bee and Vespula venom

Graffiti | Streetart

venom

Graffiti | Streetart

..venom

Graffiti | Streetart

VENOM

Graffiti | Streetart

VENOM

Graffiti | Streetart

"VENOM"-

Graffiti | Streetart

venom!

Determinants of venom-specific IgE antibody concentration during long-term wasp venom immunotherapy

Determinants of venom-specific IgE antibody concentration during long-term wasp venom immunotherapy

PD41 - Risk factors for side effects during venom immunotherapy in children with hymenoptera venom allergy

PD41 - Risk factors for side effects during venom immunotherapy in children with hymenoptera venom allergy

Omalizumab bei Kinderurtikaria

Hochschulschrift

Omalizumab bei Kinderurtikaria

Observational long-term follow-up study of rapid food oral immunotherapy with omalizumab

Observational long-term follow-up study of rapid food oral immunotherapy with omalizumab

Safety and tolerability of venom immunotherapy: evaluation of 581 rush- and ultra-rush induction protocols (safety of rush and ultra-rush venom immunotherapy)

Safety and tolerability of venom immunotherapy: evaluation of 581 rush- and ultra-rush induction protocols (safety of rush and ultra-rush venom immunotherapy)

Single venom-based immunotherapy effectively protects patients with double positive tests to honey bee and Vespula venom

Single venom-based immunotherapy effectively protects patients with double positive tests to honey bee and Vespula venom

Graffiti | Streetart

venom

Graffiti | Streetart

..venom

Graffiti | Streetart

VENOM

Graffiti | Streetart

VENOM

Graffiti | Streetart

"VENOM"-

Graffiti | Streetart

venom!

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.